| 000 | 01817 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513174523.0 | ||
| 264 | 0 | _c19990609 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0892-0362 | ||
| 024 | 7 |
_a10.1016/s0892-0362(98)00044-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeal-Beliveau, B S | |
| 245 | 0 | 0 |
_aTiming: A critical determinant of the functional consequences of neonatal 6-OHDA lesions. _h[electronic resource] |
| 260 |
_bNeurotoxicology and teratology _c |
||
| 300 |
_a129-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAging _xphysiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnimals, Newborn _xphysiology |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrooming _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
| 650 | 0 | 4 |
_aQuinpirole _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aSympatholytics _xtoxicity |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aJoyce, J N | |
| 773 | 0 |
_tNeurotoxicology and teratology _gvol. 21 _gno. 2 _gp. 129-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0892-0362(98)00044-0 _zAvailable from publisher's website |
| 999 |
_c10151707 _d10151707 |
||